MedPath

Effect of Cryotherpy on Hypertrophic Scar

Phase 2
Conditions
Hypertrophic Scars
Interventions
Device: cryotherapy (Gymna Cryoflow ICE-CT)
Other: Exercising, Positioning and splinting, Pressure Therapy and Massage
Registration Number
NCT04532840
Lead Sponsor
Zakria Mowafy
Brief Summary

Purpose of the study:

The purpose of the study is to evaluate the therapeutic effect of cryotherpy in treating hypertrophic scar.

It will be hypothesized that:

Cryotherapy may not have an effect on hypertrophic scar.

Detailed Description

The potential of cryotherapy application in vitro data indicated that using freezing treatment on VFFs + TGF-β1 (myofibroblast) modulated ECM turnover toward antifibrosis and normalization, attenuated myofibroblast differentiation, reduced cell migration, and weakened the contractile activity. On both VFFs ± TGF-β1, freezing treatment raised LP regeneration (HAS1, decorin).

The findings indicate that cryotherapy may play a protective role in scar formation and contribute to lamina regeneration.

Furthermore the need of this study was developed from the lack in the quantitative knowledge and information in the published studies about the effect of cryotherapy on hypertrophic scar.

This study will be designed to provide a guideline about the effect of effect of cryotherapy on hypertrophic scar height, thickness and discoloration, and to assist in planning an ideal treatment regimen for reducing hypertrophic scar.

Delimitations:

This study will be delimited in the following aspects:

1. Subjects:

Sixty patients suffering from hypertrophic scar will be randomly divided into two equal groups each one has 30 patients.

2. Equipment and tools:

2.1. Measurement equipment: Vancouver scar scale. MAPS (Matching Assessment of Scars and Photographs). 2.2. Therapeutic equipment: Gymna Cryoflow ICE-CT. Temperature resistant polymide tape (48 wide).

Hypothesis:

It will be hypothesized that:

Cryotherapy may not have an effect on hypertrophic scar.

Basic Assumptions:

It will be assumed that:

* All patients will receive the same kinds of medication and the same nursing care.

* All subjects are free from any chronic disease.

* All subjects will continue in the study.

* All patients will follow the instructions during the treatment

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age range between 20- 40 years.
  • Both sexes will participate in the study.
  • All patients participated will begin treatment program one month after injury depending on injury characteristics.
  • All patients enrolled to the study will have their informed consent.
Exclusion Criteria
  • Diabetes mellitus.
  • Individuals with cardiopulmonary conditions.
  • Individuals undergoing radiation therapy or chemotherapy.
  • Hepatic or pancreatic diseases.
  • Sensory impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group B: (Study group)cryotherapy (Gymna Cryoflow ICE-CT)This group includes 30 patients will receive cryotherapy (at least 10 minutes at -14 degree , 2 sessions per week , for 10 weeks ) in addition to routine medical and physical therapy treatment.
Group B: (Study group)Exercising, Positioning and splinting, Pressure Therapy and MassageThis group includes 30 patients will receive cryotherapy (at least 10 minutes at -14 degree , 2 sessions per week , for 10 weeks ) in addition to routine medical and physical therapy treatment.
Group A: (control group)Exercising, Positioning and splinting, Pressure Therapy and MassageThis group includes 30 patients will receive routine medical treatment and routine physical therapy as (Exercising, Positioning and splinting, Pressure Therapy and Massage).
Primary Outcome Measures
NameTimeMethod
scar height3 months

The potential of cryotherapy application in vitro data indicated that using freezing treatment on scar decrease its height

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Physical Therapy

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath